United Therapeutics (UTHR) Price to Book (2009 - 2026)

United Therapeutics has disclosed Price to Book across 18 years of filings, most recently posting 3.61 for Q2 2026.

• In Q2 2026, Price to Book rose 99.48% year-over-year to 3.61; the TTM figure through Jun 2026 stood at 3.61 (up 99.48% YoY), while the FY2025 annual figure was 3.0, up 22.08% from the prior year.
• Price to Book came in at 3.61 for Q2 2026 at United Therapeutics, down from 4.24 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 4.24 in Q1 2026 to a low of 1.73 in Q4 2023.
• Average Price to Book over 5 years is 2.42, with a median of 2.27 recorded in 2024.
• Year-over-year, Price to Book tumbled 35.24% in 2023 and soared 107.53% in 2026.
• Over 5 years, Price to Book stood at 2.67 in 2022, then plunged by 35.24% to 1.73 in 2023, then surged by 42.03% to 2.45 in 2024, then advanced by 22.08% to 3.0 in 2025, then grew by 20.56% to 3.61 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 3.61 in Q2 2026, 4.24 in Q1 2026, and 3.0 in Q4 2025.